<DOC>
	<DOC>NCT00180544</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety and effectiveness of the RX HERCULINK 14 Peripheral Stent System in treating atherosclerotic renal artery stenosis.</brief_summary>
	<brief_title>Safety and Effectiveness Study of the HERCULINK 14 Stent to Treat Renal Artery Disease</brief_title>
	<detailed_description>A prospective, non-randomized, multi-center, single-arm clinical trial to evaluate the safety and efficacy of the RX HERCULINKâ„¢ 14 Peripheral Stent System in the treatment of suboptimal post- procedural percutaneous transluminal angioplasty (PTA) results in de novo or restenotic atherosclerotic renal artery stenoses.</detailed_description>
	<mesh_term>Renal Artery Obstruction</mesh_term>
	<criteria>Clinical diagnosis of renal artery atherosclerosis; candidate for renal artery angioplasty and stenting; blood pressure &gt;160/90 Totally occluded renal artery on the opposite side; only one functioning kidney; target lesion is in a transplanted kidney; renal insufficiency</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>